Michelson Prizes laureates are distinguished scientists that have been recognized for their research and work to chart the future of human health.
Dennis Schaefer-Babajew, M.D., Ph.D.
Michelson Prizes: Next Generation Grants | 2023 Winner
As a Clinical Scholar, Dr. Schaefer-Babajew will study the effects of passively administered neutralizing SARS-CoV-2 antibodies on subsequent adaptive immune responses to SARS-CoV-2 vaccination in healthy adult volunteers.
Rockefeller University - Clinical Scholar, Laboratory of Molecular Immunology
Siyuan Ding, Ph.D.
Michelson Prizes: Next Generation Grants | 2023 Winner
Dr. Ding’s proposed research seeks to develop a combined vaccine for the leading viral and bacterial agents that cause infant diarrhea.
Washington University - Assistant Professor, Department of Molecular Microbiology
Claire Otero, Ph.D.
Michelson Prizes: Next Generation Grants | 2023 Winner
Dr. Otero’s research involves creating an effective vaccine for cytomegalovirus or CMV. CMV is related to viruses that cause chickenpox, herpes simplex, and mononucleosis.
Weill Cornell Medical College, Postdoctoral Associate in Pediatrics
Noam Auslander, Ph.D., Assistant Professor
Michelson Prizes: Next Generation Grants | 2022 Winner
Dr. Noam Auslander is developing an artificial intelligence-based approach to efficiently detects microbial expression in cancer and immune diseases.
Assistant Professor, Molecular & Cellular Oncogenesis Program | The Wistar Institute
Jenna Guthmiller, Ph.D., Assistant Professor
Michelson Prizes: Next Generation Grants | 2022 Winner
Dr. Jenna Guthmiller’s successful proposal will map the preexisting human B cell repertoire within the draining lymph nodes of the upper and lower respiratory tract that bind and respond to next-generation influenza vaccines.
Assistant Professor, Dept. of Immunology & Microbiology, University of Colorado Anschutz School of Medicine
Romain Guyon, Ph.D., The Jenner Institute, University of Oxford
Michelson Prizes: Next Generation Grants | 2022 Winner
Romain Guyon uses a novel microfluidics system to generate biodegradable particles that can deliver priming and booster vaccines as a single injection.
Ph.D., The Jenner Institute, University of Oxford
